All lobbying filings

RK STRATEGIES, INC.

RK STRATEGIES, INC. filed a Q2 report for CLEARMIND MEDICINE, INC on July 21, 2025, reporting $10,000 in lobbying income.

Lobbying for CLEARMIND MEDICINE, INC · Developer of Psychedelics Medicines

All filings by RK STRATEGIES, INC. · Everything CLEARMIND MEDICINE, INC has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$10,000

What the client paid this registrant for the period.

Client based in

British Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Health Issues

Psychedelic Legislation

Defense

Psychedelics legislation National Defense Authorization Act, 2026

Alcohol and Drug Abuse

Psychedelic Legislation

Veterans

Psychedelic legislation

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.